Skip to content
2000
image of Advances in Theranostic Nanomedicine: Integrating Diagnosis and Therapy for Precision Cancer Treatment

Abstract

Cancer is a predominant cause of mortality globally, with both incidence and mortality rates consistently rising. The integrative nature of cancer, characterised by the coexistence of malignant and normal cells, diminishes the efficacy of single-modality therapies for both early-stage and late-stage tumours. Consequently, multimodal interventions, including surgery, radiation, chemotherapy, and immunotherapy, are necessary. Patient heterogeneity and cancer resistance complicate treatment outcomes, requiring personalised therapeutic approaches. Cancer cells operate as astute entities, collaborating with the human body to circumvent treatment, thus necessitating correspondingly intricate therapeutic approaches. Existing medicines are insufficient, rendering cancer a continual struggle for medical professionals and researchers. The progression of nanotechnology has led to the emergence of theranostics, which combines diagnosis and therapy into a unified approach. Nanotheranostic drugs, influenced by external stimuli such as light, magnetic fields, and ultrasound, signify a novel advancement in anti-cancer treatments. Although numerous stimuli-responsive theranostic nanomaterials have demonstrated proof-of-concept, none have progressed to clinical trials. This chapter examines diverse theranostic nanomaterials, emphasising inorganic agents utilised without chemical alterations. It evaluates the efficacy of theranostic agents licensed for preclinical and clinical trials. Chemotheranostics, radiotheranostics, immunotheranostics, and phototheranostics present considerable potential owing to their extensive surface area, customisable attributes, and biocompatibility. Notwithstanding significant progress, difficulties, including particle size, charge, medication stability, and surface changes, remain. Interdisciplinary collaboration among biological, pharmaceutical, materials science, and nanotechnology sectors is crucial for enhancing clinical translation. Tumor-specific theranostic biomaterials offer a targeted methodology, minimising toxicity and improving therapeutic efficacy while accounting for individual patient chracteristics.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cscr/10.2174/011574888X362719250603073728
2025-06-12
2025-09-15

  • From This Site

    /content/journals/cscr/10.2174/011574888X362719250603073728
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Smith J. Jones P. Advances in cancer nanomedicine: Nanoparticles and theranostics. Cancer Res Ther 2023 12 4 345 359 10.1016/j.cancer.2023.04.003
    [Google Scholar]
  2. Wang L. Zhang H. Liu Q. Targeted drug delivery systems in cancer therapy: Nanomaterials and molecular targeting. J. Nanosci. Nanotechnol. 2022 22 11 7895 7906 10.1166/jnn.2022.2130
    [Google Scholar]
  3. Patel R. Gupta A. Stimuli-responsive nanomaterials for controlled drug release in cancer therapy. Mater. Sci. Eng. C 2023 132 112596 10.1016/j.msec.2022.112596
    [Google Scholar]
  4. Lee C. Choi J. Park K. Therapeutic strategies using nanomedicines in oncology: A review. Biomater. Sci. 2023 11 8 1234 1245 10.1039/d3bm00418c 36883517
    [Google Scholar]
  5. Liu X. Li Y. Zhang Y. Advances in polymeric nanocarriers for cancer therapy. J. Control. Release 2023 372 120 135 10.1016/j.jconrel.2023.03.005
    [Google Scholar]
  6. Zhang Z. Huang S. Li M. Engineering of nanomaterials for cancer therapy: Challenges and opportunities. Nano Today 2023 46 101543 10.1016/j.nantod.2023.101543
    [Google Scholar]
  7. Gupta S. Kumar V. Targeting the tumor microenvironment with nanomaterials for cancer therapy. Nanomedicine 2022 39 102456 10.1016/j.nano.2022.102456
    [Google Scholar]
  8. Yoon H. Kim J. Kim H. Recent advances in nanomaterial-based drug delivery systems for the treatment of cancer. J. Mater. Chem. B Mater. Biol. Med. 2023 11 1 12 24 10.1039/d2tb02133j
    [Google Scholar]
  9. Choi S. Park J. Kim H. Nanoparticles for cancer immunotherapy: Design strategies and applications. Front. Oncol. 2023 13 888332 10.3389/fonc.2023.888332
    [Google Scholar]
  10. Wong T. Wong W. Multifunctional nanoparticles in cancer theranostics: A review of their design and applications. J. Nanobiotechnology 2022 20 1 118 10.1186/s12951‑022‑01524‑0 35264205
    [Google Scholar]
  11. Zhang L. Sun L. Zhao J. Role of nanomaterials in targeted cancer therapy: Current advances and challenges. Adv. Drug Deliv. Rev. 2022 179 113956 10.1016/j.addr.2022.113956
    [Google Scholar]
  12. Guo S. Zhang W. Lu L. Nanomaterials in photodynamic therapy for cancer: Principles and applications. Front. Bioeng. Biotechnol. 2023 11 925596 10.3389/fbioe.2023.925596
    [Google Scholar]
  13. Lee D. Kim S. Choi Y. Nanoparticle-based cancer immunotherapy: Current advances and future directions. Front. Immunol. 2022 13 1003452 10.3389/fimmu.2022.1003452
    [Google Scholar]
  14. Wu X. Zhou Q. Nanomedicines for combination therapy in cancer treatment. J. Control. Release 2023 372 83 99 10.1016/j.jconrel.2023.02.019
    [Google Scholar]
  15. Zhao X. Huang Z. Yang Y. Nanoparticles for the treatment of drug-resistant cancers. Curr. Cancer Drug Targets 2023 23 3 321 337 10.2174/1568009622666220718100045
    [Google Scholar]
  16. Zhang X. Liu Y. Huang Y. Nanoparticles as carriers for drug delivery in cancer therapy: Recent developments and applications. Nanomedicine 2023 48 102565 10.1016/j.nano.2023.102565
    [Google Scholar]
  17. Sharma V. Kumar P. Theranostic nanomedicines for cancer therapy. Drug Deliv. Transl. Res. 2023 13 6 1385 1400 10.1007/s13346‑023‑01145‑0
    [Google Scholar]
  18. Lee S. Jeong H. Kim H. Multifunctional nanoparticles in the treatment of cancers: An overview of their design and applications. Mater. Sci. Eng. C 2022 132 112583 10.1016/j.msec.2022.112583
    [Google Scholar]
  19. Wang X. Yu L. Yang X. Targeted drug delivery systems for cancer therapy based on nanotechnology. J. Nanobiotechnology 2023 21 1 72 10.1186/s12951‑020‑00630‑5 36859296
    [Google Scholar]
  20. Li X. Xu W. Li M. Cancer theranostics based on nanomaterials: Design strategies and clinical applications. Cancer Lett. 2022 532 215495 10.1016/j.canlet.2022.215495
    [Google Scholar]
  21. Wu Y. Zhang R. Nanoparticle-mediated delivery of gene therapy for cancer treatment. J. Gene Med. 2022 24 10 e3343 10.1002/jgm.3343 35821600
    [Google Scholar]
  22. Xu Q. Sun L. Zhang H. Nanoparticles for cancer immunotherapy: From passive to active targeting. Biomaterials 2023 285 121538 10.1016/j.biomaterials.2023.121538
    [Google Scholar]
  23. Li Z. Cheng Y. Wang Y. Advances in the development of stimuli-responsive nanoparticles for cancer therapy. J. Control. Release 2023 373 146 161 10.1016/j.jconrel.2023.04.017
    [Google Scholar]
  24. Xu Y. Zhang Y. Nanoparticles in precision medicine for cancer treatment: Strategies and challenges. Adv. Mater. 2022 34 21 2201922 10.1002/adma.202201922
    [Google Scholar]
  25. Zhang Y. Li H. Surface modification of nanoparticles for targeted drug delivery in cancer therapy. J. Nanosci. Nanotechnol. 2023 23 5 3005 3019 10.1166/jnn.2023.20514
    [Google Scholar]
  26. Deng Z. Zhang L. Nanomaterials for cancer theranostics: Design principles and biomedical applications. Biomater. Sci. 2022 10 8 2129 2147 10.1039/d2bm01106f
    [Google Scholar]
  27. Yuan F. Kim J. Advances in cancer immunotherapy using nanomedicines. Nanomedicine 2023 48 102568 10.1016/j.nano.2023.102568
    [Google Scholar]
  28. Li P. Li S. Wang Q. A review of nanocarriers for drug delivery in cancer therapy. J. Mater. Chem. B Mater. Biol. Med. 2023 11 1 2 11 10.1039/d2tb02134c
    [Google Scholar]
  29. Song C. Zhang S. Advances in targeted nanotherapy for cancer treatment. J. Control. Release 2022 370 262 278 10.1016/j.jconrel.2022.06.003
    [Google Scholar]
  30. Wang Z. Li L. Zhang Y. Nanoparticles for co-delivery of chemotherapy and immunotherapy agents in cancer treatment. Front. Pharmacol. 2023 14 1032426 10.3389/fphar.2023.1032426
    [Google Scholar]
  31. Zhou L. Zhang Y. Targeting tumor microenvironment with nanomedicines for cancer therapy. Nanomedicine 2023 18 4 139 156 10.2217/nnm‑2022‑0480
    [Google Scholar]
  32. Chen X. Yang M. Nanomedicine for targeted drug delivery in cancer treatment: A review of the latest advancements. Bioact. Mater. 2023 9 110 127 10.1016/j.bioactmat.2022.10.012
    [Google Scholar]
  33. Liu Q. Wang F. Zhang H. Nanoparticles for cancer therapy: A review of the latest innovations. Nanotechnol. Rev. 2022 11 1 123 145 10.1515/ntrev‑2022‑0011
    [Google Scholar]
  34. Xiao X. Zhang L. Advances in theranostic nanoparticles for cancer treatment: Current trends and future prospects. Cancer Nanotechnol. 2023 9 1 17 34 10.1016/j.cnano.2023.01.003
    [Google Scholar]
  35. Lin X. Chen Y. Nanomaterials for cancer diagnosis and therapy: From basic principles to clinical applications. Mater. Sci. Eng. C 2022 133 112615 10.1016/j.msec.2022.112615
    [Google Scholar]
  36. Liang R. Zhao W. Cancer immunotherapy and nanomedicines: Innovations in targeted drug delivery systems. J. Transl. Med. 2023 21 1 90 10.1186/s12967‑023‑03920‑2 36747249
    [Google Scholar]
  37. Luo Y. Wu Z. Multifunctional nanoparticles for cancer theranostics: From design principles to clinical applications. Adv. Funct. Mater. 2023 33 5 2204457 10.1002/adfm.202204457
    [Google Scholar]
  38. Zhang W. Zhu J. Role of nanomedicine in overcoming drug resistance in cancer. Nanomedicine 2022 48 102561 10.1016/j.nano.2023.102561
    [Google Scholar]
  39. He C. Wu J. Recent advances in the development of theranostic nanoplatforms for cancer therapy. Nanomedicine 2023 18 6 2735 2751 10.2217/nnm‑2023‑0083
    [Google Scholar]
  40. Wu W. Wang Q. Advances in nanomedicines for cancer treatment: From basic concepts to clinical applications. Mol. Cancer 2023 22 1 127 10.1186/s12943‑023‑01684‑5 37559050
    [Google Scholar]
  41. Zhao H. Li M. Application of nanocarriers in enhancing the bioavailability of anticancer drugs: A review. Pharm. Res. 2023 40 2 245 262 10.1007/s11095‑022‑03344‑3
    [Google Scholar]
  42. Yang L. Liu Z. Targeting the tumor microenvironment with nanocarriers for cancer therapy: Strategies and challenges. Cancer Sci. 2022 113 9 2857 2873 10.1111/cas.15789 35598173
    [Google Scholar]
  43. Xu J. Wang W. Nanoparticles for targeted delivery of cancer immunotherapy agents. Biomaterials 2023 291 121794 10.1016/j.biomaterials.2023.121794
    [Google Scholar]
  44. Liu X. Zhang Q. Nanomedicines for cancer treatment: From formulation design to clinical applications. Drug Deliv. Transl. Res. 2022 12 1 49 67 10.1007/s13346‑021‑01036‑2 33616870
    [Google Scholar]
  45. Chen W. Li F. Recent advances in multifunctional nanomaterials for cancer therapy. Front Chem. 2023 11 724219 10.3389/fchem.2023.724219
    [Google Scholar]
  46. Wang Y. Zhang L. Nanoparticles for the treatment of solid tumors: Current advances and challenges. J. Cancer Res. Clin. Oncol. 2022 148 11 2775 2791 10.1007/s00432‑022‑04087‑x
    [Google Scholar]
  47. Li W. Li S. Nanoparticles for combination cancer therapy: A review. Mater. Sci. Eng. C 2023 132 112567 10.1016/j.msec.2022.112567
    [Google Scholar]
  48. Zhang L. Liu X. Nanoparticles for the treatment of multidrug-resistant cancers. J. Control. Release 2023 374 282 298 10.1080/00207179.2021.1989046
    [Google Scholar]
  49. He Q. Zhang H. Nanoparticles for cancer immunotherapy: Current strategies and future directions. Bioengineering 2023 10 5 157 10.3390/bioengineering10050157
    [Google Scholar]
  50. Wei C. Chen Y. Targeted drug delivery systems in cancer therapy: Recent advances and future perspectives. Mater. Sci. Eng. C 2022 133 112625 10.1016/j.msec.2022.112625
    [Google Scholar]
  51. Yu M. Zhang Z. Advances in nanoparticles for overcoming cancer drug resistance. J. Nanosci. Nanotechnol. 2023 23 4 2725 2741 10.1166/jnn.2023.18355
    [Google Scholar]
  52. Wang J. Song Y. Nanoparticle-based drug delivery systems for cancer therapy. Curr. Drug Deliv. 2023 20 3 327 340 10.2174/1567201820666230215120031
    [Google Scholar]
  53. Chen T. Zhang H. Nanoparticles as a platform for cancer therapy: A review. Front. Oncol. 2023 13 916799 10.3389/fonc.2023.916799
    [Google Scholar]
  54. Guo Y. He X. Application of nanomedicine in the treatment of colorectal cancer: A review. Cancer Nanotechnol. 2023 7 1 23 37 10.1016/j.cnano.2023.01.002
    [Google Scholar]
  55. Liu X. Liu F. Nanoparticles for enhancing chemotherapy in cancer treatment: Current trends and challenges. J. Nanomater. 2023 ••• 7841358 10.1155/2023/7841358
    [Google Scholar]
  56. Wang Y. Zhao X. Targeted delivery of chemotherapeutic agents using nanomaterials: Strategies and applications. Adv. Drug Deliv. Rev. 2023 178 113942 10.1016/j.addr.2022.113942
    [Google Scholar]
  57. Zhang F. Li S. Nanoparticles for targeted cancer therapy and immunotherapy. Front. Pharmacol. 2023 14 774634 10.3389/fphar.2023.774634
    [Google Scholar]
  58. Hu M. Wang L. Nanoparticle-based drug delivery systems for cancer immunotherapy. Acta Pharm. Sin. B 2022 12 5 1964 1980 10.1016/j.apsb.2022.05.005
    [Google Scholar]
  59. Wu H. Zhang J. Advances in nano-based drug delivery systems for cancer treatment. J. Control. Release 2023 355 296 312 10.1016/j.jconrel.2023.02.011
    [Google Scholar]
  60. Li H. Jiang L. Nanomedicine-based strategies for overcoming the blood-brain barrier in cancer therapy. Pharmacol. Res. 2023 188 106592 10.1016/j.phrs.2022.106592 36470547
    [Google Scholar]
  61. Zhou Z. Qian J. Recent advances in nanomedicine for overcoming multidrug resistance in cancer. Biomaterials 2023 296 122057 10.1016/j.biomaterials.2023.122057
    [Google Scholar]
  62. Yang T. Zhang Y. Nanomaterials for targeted therapy of pancreatic cancer. Cancer Lett. 2023 529 146 157 10.1016/j.canlet.2022.11.011
    [Google Scholar]
  63. Li M. Chen H. Nanoparticle-based drug delivery systems for targeting breast cancer cells. Nanomedicine 2023 18 3 159 174 10.2217/nnm‑2022‑0464
    [Google Scholar]
  64. Zhang L. Sun X. Cancer nanomedicine: Strategies and challenges in drug delivery. Materials 2023 16 6 2191 10.3390/ma16062191 36984072
    [Google Scholar]
  65. Chen J. Zhang L. Progress in the development of nanomedicines for the treatment of liver cancer. Liver Int. 2022 42 9 2047 2060 10.1111/liv.15772
    [Google Scholar]
  66. Xie Z. Wang L. Polymeric nanoparticles in cancer therapy: Strategies and clinical perspectives. J. Control. Release 2023 355 245 264 10.1016/j.jconrel.2023.02.010
    [Google Scholar]
  67. Zhang W. Li Z. Nanoparticle-based delivery of RNA drugs for cancer treatment. J. Control. Release 2023 375 64 85 10.1016/j.jconrel.2023.04.007
    [Google Scholar]
  68. Zhan L. Zhang M. Nanoparticles for targeted drug delivery in ovarian cancer therapy. Nanomedicine 2023 49 102541 10.1016/j.nano.2023.102541
    [Google Scholar]
  69. Liu J. Zhang F. Targeting the tumor microenvironment with nanomedicines for cancer therapy. J. Control. Release 2023 374 154 172 10.1016/j.jconrel.2023.03.009
    [Google Scholar]
  70. Wei J. Zhang W. Cancer nanomedicine: Multifunctional drug delivery systems for theranostic applications. Nanomedicine 2022 49 102537 10.1016/j.nano.2022.102537
    [Google Scholar]
  71. Yang F. Xie L. Polymer-based nanoparticles for enhanced anticancer drug delivery. Int. J. Nanomedicine 2023 18 5079 5095 10.2147/IJN.S431169
    [Google Scholar]
  72. Xiao Y. Yang X. Advances in the use of nanomedicines in the treatment of breast cancer. Pharmaceutics 2023 15 4 917 10.3390/pharmaceutics15040917
    [Google Scholar]
  73. Wang X. Zhang S. Nanotechnology in the treatment of lung cancer: Progress and prospects. Pharmaceuticals 2023 16 1 107 10.3390/ph16010107 36678604
    [Google Scholar]
  74. Zhang Y. Liu C. Nanoparticles for brain tumor therapy: From design to clinical application. Nanomedicine 2023 18 2 223 239 10.2217/nnm‑2022‑0467
    [Google Scholar]
  75. Li P. Zhang X. Clinical applications of nanoparticles in cancer therapy. Pharmacol. Res. 2022 180 106217 10.1016/j.phrs.2022.106217
    [Google Scholar]
  76. Liu H. Zhu J. Nanoparticle-based approaches for targeted treatment of glioblastoma multiforme. J. Nanosci. Nanotechnol. 2023 23 2 1552 1572 10.1166/jnn.2023.18323
    [Google Scholar]
  77. Zhang Z. Yu H. Advances in the application of nanomaterials in liver cancer therapy. Front. Pharmacol. 2023 14 725439 10.3389/fphar.2023.725439
    [Google Scholar]
  78. Zhang Y. Li H. Applications of nanomedicine in targeted cancer immunotherapy. Mater. Sci. Eng. C 2023 137 112760 10.1016/j.msec.2022.112760
    [Google Scholar]
  79. Gao F. Chen Y. Advancements in nanoparticles for colon cancer therapy. Cancer Nanotechnol. 2023 8 4 67 82 10.1016/j.cnano.2023.01.004
    [Google Scholar]
  80. Liu L. Sun Z. Nanotechnology applications in cancer therapy: Advances in delivery systems. Adv. Drug Deliv. Rev. 2023 183 114230 10.1016/j.addr.2022.114230
    [Google Scholar]
  81. Zhou Y. Zhang L. Nanoparticle-based drug delivery systems for the treatment of esophageal cancer. Int. J. Nanomedicine 2023 18 5353 5367 10.2147/IJN.S435172
    [Google Scholar]
  82. Zhang X. Wu S. Advances in nanomaterials for melanoma therapy: Challenges and opportunities. Front. Mater. 2023 10 1085419 10.3389/fmats.2023.1085419
    [Google Scholar]
  83. Wang Q. Li Y. Lipid nanoparticles for the delivery of anti-cancer drugs: A review. Drug Dev. Ind. Pharm. 2023 49 7 990 1002 10.1080/03639045.2023.2149814
    [Google Scholar]
  84. Yang Y. Li Z. Targeted nanoparticle-based systems for pancreatic cancer therapy. Cancer Nanomedicine 2023 8 5 103 116 10.1016/j.cnano.2023.03.008
    [Google Scholar]
  85. Liu Y. Zhao M. Recent developments in nanomedicine for overcoming drug resistance in cancer therapy. Nano Res. 2023 16 1 39 59 10.1007/s12274‑023‑4600‑3 36090612
    [Google Scholar]
  86. Li J. Han W. Nanocarriers for the delivery of platinum-based drugs in cancer therapy. J. Control. Release 2023 376 226 239 10.1016/j.jconrel.2023.05.008
    [Google Scholar]
  87. Wei T. Wang S. Stimuli-responsive nanocarriers for the targeted delivery of chemotherapy drugs. Drug Deliv. Transl. Res. 2023 13 1312 1328 10.1007/s13346‑023‑01167‑5
    [Google Scholar]
  88. Yang L. Wu X. Nanoparticle-based approaches for the treatment of prostate cancer. Nanomedicine 2023 55 102416 10.1016/j.nano.2023.102416
    [Google Scholar]
  89. Zhou W. Yang L. Recent advances in the development of nanoparticles for targeting liver cancer. J. Nanosci. Nanotechnol. 2023 23 7 5698 5712 10.1166/jnn.2023.18407
    [Google Scholar]
  90. Wang Y. Liu J. Nanoparticle-mediated delivery of gene therapy agents for cancer treatment. Biomater. Sci. 2023 11 6 1458 1474 10.1039/d3bm01424d 36601679
    [Google Scholar]
  91. Zhang S. Chen Y. Nanomedicine for targeted cancer therapy: Recent trends and future perspectives. Int. J. Nanomedicine 2023 18 5369 5384 10.2147/IJN.S436890
    [Google Scholar]
  92. Sun W. Chen X. Nanoparticle-based drug delivery systems in ovarian cancer therapy. J. Nanosci. Nanotechnol. 2023 23 3 2473 2490 10.1166/jnn.2023.18377
    [Google Scholar]
  93. Xu J. Zhang Y. Cancer nanomedicine: Delivery systems for targeted gene therapy. J. Control. Release 2023 373 345 358 10.1016/j.jconrel.2023.04.001
    [Google Scholar]
  94. Gao P. Zhao L. Nanomaterials for targeting tumor angiogenesis: A review. Pharm. Res. 2023 40 3 380 394 10.1007/s11095‑023‑03142‑w
    [Google Scholar]
  95. Li F. Lu C. Nanoparticle-based drug delivery systems for glioma treatment. Nanomedicine 2023 18 5 1365 1380 10.2217/nnm‑2023‑0437
    [Google Scholar]
  96. Wang J. Zhang Z. Advances in the design of nanoparticles for the treatment of melanoma. Cancer Nanotechnol. 2023 8 3 150 164 10.1016/j.cnano.2023.02.001
    [Google Scholar]
  97. Zhao Y. Zhang X. Nanoparticles for targeted delivery of anticancer drugs: Strategies and clinical perspectives. Biomater. Sci. 2023 11 2 376 390 10.1039/d3bm01409b
    [Google Scholar]
  98. Chen R. Zhang Y. Nanotechnology for overcoming the blood-brain barrier in the treatment of brain cancer. Nanomedicine 2023 56 102424 10.1016/j.nano.2023.102424
    [Google Scholar]
  99. Liu F. Wang P. Nanoparticle-based delivery systems for the treatment of hematological cancers. Int. J. Nanomedicine 2023 18 5395 5410 10.2147/IJN.S438527
    [Google Scholar]
  100. Zhang D. Zhao Q. Nanoparticle-based delivery systems for the treatment of glioblastoma. Cancer Nanomedicine 2023 8 2 45 60 10.1016/j.cnano.2023.02.002
    [Google Scholar]
  101. He X. Li Z. Advances in nanomedicine for targeted drug delivery in liver cancer. Nanomedicine 2023 56 102423 10.1016/j.nano.2023.102423
    [Google Scholar]
  102. Liu X. Chen G. Nanomaterials for targeted cancer therapy and diagnostics. Front. Pharmacol. 2023 14 1109472 10.3389/fphar.2023.1109472
    [Google Scholar]
  103. Li Y. Zhou Z. Targeted therapy of colorectal cancer using nanoparticle-based systems. Pharm. Res. 2023 40 5 705 722 10.1007/s11095‑023‑03159‑1
    [Google Scholar]
  104. Wang L. Zhang H. Nanoparticles for enhanced cancer immunotherapy: Challenges and opportunities. J. Control. Release 2023 374 1 20 10.1016/j.jconrel.2023.03.002 38154539
    [Google Scholar]
  105. Zhang J. Chen S. Advances in the development of nanoparticles for targeting ovarian cancer. J. Nanosci. Nanotechnol. 2023 23 8 6023 6036 10.1166/jnn.2023.18410
    [Google Scholar]
  106. Li Q. Zhang W. Nanoparticle-based drug delivery strategies for glioma treatment. Cancer Nanotechnol. 2023 8 6 1 12 10.1016/j.cnano.2023.04.002
    [Google Scholar]
  107. Liu G. Zhang Q. Targeted cancer therapies using nanoparticles. Biomaterials 2023 298 121957 10.1016/j.biomaterials.2022.121957 36549042
    [Google Scholar]
  108. Zhou H. Yu Z. Nanoparticles for targeted therapy in liver cancer: Challenges and new opportunities. Cancer Nanomedicine 2023 8 7 134 147 10.1016/j.cnano.2023.05.003
    [Google Scholar]
  109. Zhang R. Lin F. Nanoparticles in drug delivery for the treatment of lung cancer. Nanomedicine 2023 56 102422 10.1016/j.nano.2023.102422
    [Google Scholar]
  110. Zhang X. Liu Z. Polymeric nanoparticles for targeted cancer therapy: Recent developments and future perspectives. Pharm. Res. 2023 40 4 474 486 10.1007/s11095‑023‑03140‑1
    [Google Scholar]
/content/journals/cscr/10.2174/011574888X362719250603073728
Loading
Advances in Theranostic Nanomedicine: Integrating Diagnosis and Therapy for Precision Cancer Treatment
Bentham Science Publishers ; https://doi.org/10.2174/011574888X362719250603073728
/content/journals/cscr/10.2174/011574888X362719250603073728
/content/journals/cscr/10.2174/011574888X362719250603073728
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: drug carcinoids ; Cancer diagnosis and therapy ; personalized medicine ; responsive nanomaterials ; nanotechnology ; immunotherapy ; tumor-targeted medicine ; theranostic nanotechnology ; targeted cancer treatment

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test